90471-79-7 Chemical Name: L-Carnitine fumarate Synonyms CARNITINE FUMARATE;zxrjfmsy;L-CRNITINEFUMARATE;L-CARNITINE FUMARATE;L-CARNITINE-L-FUMARATE;L-CARNITINEFUMARATE,POWDER;L-CARNITINE FUMARATE FINE (DURACARN);L-Crnitine fumarate (factory standard);(R)-(3-Carboxy-2-hydroxypropyl)-trimethyl ammonium fumarate;(R)-(3-carboxy-2-hydroxypropyl)trimethylammonium hydrogen fumarate CBNumber: CB2698142 Molecular Formula: C11H19NO7 Molecular Weight: 277.27 MDL Number: MFCD01631178 MOL File: 90471-79-7.mol MSDS File: SDS Last updated:2026-05-28 00:42:26 L-Carnitine fumarate Properties SAFETY Risk and Safety Statements L-Carnitine fumarate price L-Carnitine fumarate Chemical Properties,Uses,Production Chemical Properties White or off-white crystalline powder L-Carnitine fumarate Preparation Products And Raw materials Raw materials Preparation Products View Lastest Price from L-Carnitine fumarate manufacturers L-Carnitine fumarate 90471-79-7 $5.00 99% Henan Fengda Chemical Co., Ltd L-Carnitine fumarate 90471-79-7 $9.00 99.9 Hebei Chuanghai Biotechnology Co,.LTD L-Carnitine fumarate 90471-79-7 $10.00 99.5% Hebei Chuanghai Biotechnology Co., Ltd L-Carnitine fumarate Spectrum 90471-79-7(L-Carnitine fumarate )Related Search: (R)-(3-Carboxy-2-hydroxypropyl)-trimethyl ammonium fumarate L-CRNITINEFUMARATE L-CARNITINE FUMARATE FINE (DURACARN) L-CARNITINEFUMARATE,POWDER L-CARNITINE FUMARATE (R)-(3-carboxy-2-hydroxypropyl)trimethylammonium hydrogen fumarate L-CARNITINE-L-FUMARATE (R)-3-Carboxy-2-hydroxy-N,N,N-trimethylpropan-1-aminium (E)-3-carboxyacrylate L-Crnitine fumarate (factory standard) 1-Propanaminium, 3-carboxy-2-hydroxy-N,N,N-trimethyl-, (2R)-,(2E)-2-butenedioate (1:1) (salt)OTHER CA INDEX NAMES:2-Butenedioic acid (2E)-, ion(1-),(2R)-3-carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium zxrjfmsy CARNITINE FUMARATE 90471-79-7 C7H16NO3C4H3O4C11H19NO7 C11H19NO7 C7H15NO3C4H4O4 C7H16NO3C4H3O4C11H L-Carnitine Series Vitamins and derivatives Nutraceuticals 90471-79-7
Theyre finally back in stock
Presentacin prctica para quienes buscan integrarlo de forma sencilla a su da
Studies uncover a robust association between EDS and HE, with 38% of cirrhosis patients experiencing EDS, 89.5% of whom also manifest overt HE
